Title:
INDANONE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/254416
Kind Code:
A1
Abstract:
A compound as represented by formula (I), a composition and formulation comprising such compound, and a method for using and preparing such compound. The compound is used for treating diseases mediated by HIF-2α.
Inventors:
YANG RONGWEN (CN)
SUN YUN (CN)
LI YABIN (CN)
WANG PINGPING (CN)
LAN HONG (CN)
DING LIEMING (CN)
WANG JIABING (CN)
SUN YUN (CN)
LI YABIN (CN)
WANG PINGPING (CN)
LAN HONG (CN)
DING LIEMING (CN)
WANG JIABING (CN)
Application Number:
PCT/CN2021/100485
Publication Date:
December 23, 2021
Filing Date:
June 17, 2021
Export Citation:
Assignee:
BETTA PHARMACEUTICALS CO LTD (CN)
International Classes:
C07C49/755; A61K31/085; A61K31/122; A61P35/00
Domestic Patent References:
| WO2017218960A1 | 2017-12-21 | |||
| WO2020081695A1 | 2020-04-23 | |||
| WO2016145045A1 | 2016-09-15 | |||
| WO2016145032A1 | 2016-09-15 | |||
| WO2016144825A1 | 2016-09-15 | |||
| WO2016168510A1 | 2016-10-20 | |||
| WO2017053192A1 | 2017-03-30 | |||
| WO2016057242A1 | 2016-04-14 | |||
| WO2019191227A1 | 2019-10-03 |
Download PDF:
Previous Patent: TIME WINDOW-BASED AGV INTELLIGENT SCHEDULING METHOD
Next Patent: BICYCLIC COMPOUND AND APPLICATION THEREOF
Next Patent: BICYCLIC COMPOUND AND APPLICATION THEREOF